Retirement Systems of Alabama Has $3.83 Million Stake in Amedisys, Inc. (NASDAQ:AMED)

Retirement Systems of Alabama reduced its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 1.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,641 shares of the health services provider’s stock after selling 636 shares during the quarter. Retirement Systems of Alabama owned 0.12% of Amedisys worth $3,826,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Arizona State Retirement System increased its position in shares of Amedisys by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock worth $840,000 after purchasing an additional 177 shares in the last quarter. Signaturefd LLC grew its stake in Amedisys by 20.9% during the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock worth $132,000 after buying an additional 236 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Amedisys by 7.2% during the third quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider’s stock worth $365,000 after buying an additional 255 shares in the last quarter. CWM LLC increased its holdings in shares of Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock worth $211,000 after buying an additional 277 shares in the last quarter. Finally, Creative Planning raised its stake in shares of Amedisys by 7.4% in the second quarter. Creative Planning now owns 4,295 shares of the health services provider’s stock valued at $394,000 after acquiring an additional 295 shares during the last quarter. 94.36% of the stock is owned by institutional investors.

Amedisys Stock Down 1.4 %

NASDAQ AMED opened at $83.78 on Friday. The stock’s 50 day simple moving average is $91.75 and its 200 day simple moving average is $94.68. Amedisys, Inc. has a one year low of $83.73 and a one year high of $98.95. The firm has a market cap of $2.74 billion, a PE ratio of 33.25, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. During the same quarter in the previous year, the company posted $0.98 EPS. Amedisys’s revenue for the quarter was up 5.7% on a year-over-year basis. As a group, sell-side analysts forecast that Amedisys, Inc. will post 4.45 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.